Type II Diabetes Clinical Trials

77 clinical trials for Type II Diabetes across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The GRoceries Aimed at Increasing Nutrition Study — RECRUITING · NA
• Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus — RECRUITING · PHASE3
• Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients — RECRUITING · NA
• Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT — RECRUITING · PHASE4
• Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. — RECRUITING
• A single-center, double-blind, randomized, placebo-controlled, cross-over study to assess the effect of vildagliptin on glucagon counterregulatory response during hypoglycemia in patients with type 2 diabetes — COMPLETED · PHASE3
• A multicenter, double-blind, randomized, active controlled study to compare the effect of long term treatment with LAF237 50 mg bid to gliclazide up to 320 mg daily in drug naïve patients with type 2 diabetes — COMPLETED · PHASE3
• A one-year multicentre, international, randomised, double-blind study with comparison of benfluorex (150 mg od to 150 mg tid) versus pioglitazone (30 mg od to 45 mg od) in combination with sulfonylurea administered orally for the treatment of type 2 diabetes. — COMPLETED · PHASE3
• A randomized, double-blind, placebo-controlled, parallel-group, multicenter 12-week study assessing the efficacy and safety of AVE0010 in patients with type 2 diabetes not treated with antidiabetic agents. — COMPLETED · PHASE3
• A randomized, double-blind, placebo-controlled, parallel-group, multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top of metformin in patients with type 2 diabetes not adequately controlled with metformin. — COMPLETED · PHASE3
• A multicenter, double-blind, randomized, active controlled study to compare the effect of 52 weeks treatment with vildagliptin 50 mg bid to pioglitazone 30 mg daily as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy — COMPLETED · PHASE3
• A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top of a sulfonylurea in patients with type 2 diabetes not adequately controlled with sulfonylurea — COMPLETED · PHASE3
• A single-center, double-blind, randomized, placebo-controlled, cross-over study to assess the effect of vildagliptin on the incretin effect in patients with type 2 diabetes treated with metformin — COMPLETED · PHASE3
• A multicenter, randomized, double-blind study to compare the effects of 24 weeks treatment with LAF237 (50 mg qd, 50 mg bid or 100 mg qd) to placebo in drug naïve patients with type 2 diabetes — COMPLETED · PHASE3
• Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects — COMPLETED · PHASE1
• Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the "Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprotégérine (RANKL / OPG) System in Patients Living With Type II Diabetes — COMPLETED · NA
• Dietary Approaches to Stop Hypertension for Diabetes — COMPLETED · NA
• Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging — COMPLETED · NA
• Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes — COMPLETED · NA
• INTEGRATE-D: A Pilot Test to Support Integration of Medical and Psychosocial Care for People With Type II Diabetes — COMPLETED · NA
• Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst Scaling — COMPLETED
• Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment — COMPLETED
• Effectiveness of an mHealth Mobile App — OTHER · NA
• The Effects of Raspberry Leaf Tea on Blood Glucose Control — OTHER · NA
• A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378 — COMPLETED · PHASE1
• Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes — COMPLETED · NA
• Passive Stretching Versus Electrical Stimulation on Glucose Level, in Elderly With Type II Diabetes — OTHER · NA
• Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults — COMPLETED · PHASE1
• Burger Allen Exercises in Knee OA With Type II Diabetes — COMPLETED · NA
• Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) — COMPLETED · PHASE3
• Postbiotic MBS and Metformin Combination in Patients With T2DM — COMPLETED · NA
• Mass Balance and Biotransformation of [14C]HSK7653 in Human — COMPLETED · PHASE1
• Association Between Natural Hypoglycemic Foods and Blood Sugar Level: A Pilot Study — OTHER · NA
• A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers — OTHER · PHASE1
• A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects — OTHER · PHASE1
• Educational Intervention Targeting Statin Therapy and Compliance in Diabetic Patients — COMPLETED
• Social Incentives to Improve Diabetes — COMPLETED · NA
• A Study to Investigate the PK and Safety of CKD-393 — COMPLETED · PHASE1
• SOKARY Mobile Application With Type II Diabetes — COMPLETED
• Supplementation of Brown Seaweed on Insulin Resistance of NAFLD Patients With Pre- or Type 2-Diabetes — OTHER · NA
• Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 — COMPLETED · PHASE1
• The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients — WITHDRAWN · PHASE2
• Peer Support Dyads in Churches — COMPLETED · NA
• Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects — COMPLETED · PHASE1
• Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin — COMPLETED · PHASE3
• Providing Preventive Periodontal Treatment to Hospitalized Patients With Diabetes — COMPLETED · NA
• Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration — COMPLETED · NA
• Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes — COMPLETED · PHASE3
• Periodontal Treatment Response in Type II Diabetic Patients — COMPLETED
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults — OTHER · PHASE1

Refine this search